Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 45 for:    Asklepios BioPharmaceutical
Previous Study | Return to List | Next Study

NAN-101 in Patients With Class III Heart Failure (NAN-CS101)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04179643
Recruitment Status : Recruiting
First Posted : November 27, 2019
Last Update Posted : March 9, 2021
Sponsor:
Information provided by (Responsible Party):
Asklepios Biopharmaceutical, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : December 31, 2024